Adagio Medical Holdings, Inc. (ADGM) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US00534B1008
Adagio Medical Holdings, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 0.00 USD |
| Gross profit | -684,000.00 USD |
| Operating income | -21.89 m USD |
| EBIT | -22.66 m USD |
| Net income | -25.08 m USD |
| Diluted EPS – continuing operations | -1.51 USD |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Adagio Medical Holdings, Inc.
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
More stocks
- Presidio Property Trust, Inc. (SQFT)
- Matinas BioPharma Holdings, Inc. (MTNB)
- Cybin Inc (HELP.NE)
- HEALTHY CHOICE WELLNESS CORP. (HCWC)
- ORAGENICS INC (OGEN)
- Kaya Holdings, Inc. (KAYS)
- GPO Plus, Inc. (GPOX)
- Ocean Thermal Energy Corp (CPWR)
- Sirius Media (ALSRS.PA)
- Odyssey Health, Inc. (ODYY)
- AVENUE THERAPEUTICS, INC. (ATXI)
- Catheter Precision, Inc. (VTAK)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.